Skip to main content
All blogsPersona Guide

Peptides for Veterans: A Science-Based Look at TBI, PTSD, and Recovery Support

For veterans navigating traumatic brain injury, PTSD, and the long tail of recovery, the internet is full of peptide sellers and short on honesty. This is the honest version: where the research on Semax, Selank, BPC-157, and NAD+ actually stands, how these might sit alongside VA care rather than replace it, and the medication-safety question no one else answers.

PeRx Peptides14 min readUpdated June 7, 2026
TBI and PTSD frequently occur together in veterans, and both have treatments with real evidence. Peptides, at most, sit alongside that care, never in place of it.
TBI and PTSD frequently occur together in veterans, and both have treatments with real evidence. Peptides, at most, sit alongside that care, never in place of it.

Key Takeaways

  • This guide is an adjunct-to-care resource, not a treatment plan. Semax, Selank, BPC-157, and NAD+ are not FDA-approved and are not a substitute for VA care or the evidence-based treatments for TBI and PTSD. Coordinate anything you consider with your care team.
  • The research maps to symptom areas, not diagnoses: Selank has been studied for anxiety, Semax for cognition and mood, BPC-157 for tissue and neural recovery in animal models, and NAD+ for cellular energy and brain fog. The human evidence ranges from limited to preliminary.
  • The question almost no one answers responsibly is medication safety. If you take SSRIs or other VA-prescribed medications, the interaction question, especially with Selank and the serotonin system, must be evaluated by your prescriber before you start anything.
  • The biggest real-world risk is gray-market sourcing, including veteran-branded resellers selling unregulated "research" vials. Provider oversight and a legitimate pharmacy matter more than any label or discount.

Quick Facts

Audience

Adult veterans exploring recovery support, and their families

Framing

Adjunct to VA care, not a replacement or a cure

Peptides discussed

Semax, Selank, BPC-157, NAD+

Symptom areas researched

Cognition, mood and anxiety, tissue and neural recovery, energy

Regulatory status

None are FDA-approved; all are prescription-only

First step

Coordinate with the provider who manages your care and medications

Before Anything Else

Read this first

This is an educational resource, not a treatment plan and not medical advice. The peptides discussed here are not FDA-approved, and nothing in this guide is a substitute for VA care or for the evidence-based treatments for traumatic brain injury and PTSD. If you are in crisis, the Veterans Crisis Line is available by dialing 988 and pressing 1. Anything you consider here should be coordinated with the provider who manages your care.

There is a lot of noise around peptides and veterans, and not much straight talk. The questions that actually matter are simple ones: what does the research say, where might these compounds honestly fit, and what are the real cautions. That is what this guide is for. It treats you like an adult who can handle an honest picture, including the parts where the honest picture is "the evidence is thin and you should talk to your provider."

The frame that matters throughout: traumatic brain injury and PTSD are serious, well-studied conditions, and they frequently occur together in veterans. They have treatments with real evidence behind them, delivered through the VA and civilian care systems. Peptides are not those treatments. At most, for some people, certain peptides may play a supportive role around the edges of established care, for symptoms like cognitive fog, anxiety, low energy, or slow physical recovery. Keeping that frame in view is what makes the rest of this guide useful.

How These Fit Alongside VA Care

The useful way to think about peptides here is not by diagnosis but by symptom area. Veterans recovering from TBI and PTSD often describe a cluster of issues, cognitive fog and trouble focusing, anxiety and a nervous system stuck on high alert, low energy and fatigue, and the slow physical recovery that follows injury. Different peptides have been researched in relation to different parts of that cluster. The table below maps that, with the evidence stated plainly and the same caveat on every row: this is research interest in a symptom area, not an approved treatment for a condition.

Symptom areaResearched peptideWhat the research suggestsThe honest caveat
Cognition and focusSemaxResearch interest in attention, mental clarity, and a proposed effect on BDNF, a brain growth factorMostly Russian clinical data; thin Western trial base; not approved for TBI
Anxiety and moodSelankStudied as an anxiolytic, with research in generalized anxietyLimited human data; not an approved PTSD treatment; serotonin-pathway interactions
Tissue and neural recoveryBPC-157Animal-model research on tissue healing, including a traumatic brain injury mouse modelPreclinical; no human TBI trials; human evidence does not yet exist
Energy and fatigueNAD+A coenzyme central to cellular energy; rationale for supporting energy and brain fogMechanistic and emerging human evidence; not a treatment for any condition

Semax and Selank: Cognition and Mood

Selank and Semax are the two peptides most often raised in the veteran context, and they are worth understanding together because they target the two halves of the cognitive-emotional cluster. Both were developed in Russia, where they are approved and used clinically, which is genuinely different from FDA approval and should be read that way. In the US they are investigational, prescription-only compounds.

Semax is the one with research interest in cognition: attention, mental clarity, and a proposed effect on BDNF, a brain-derived growth factor involved in learning and neural health. For a veteran describing post-concussive fog or trouble sustaining focus, that is the symptom it speaks to, and it is the same focus-peptide raised in non-medical long-session cognitive contexts. Selank is weighted toward the other half, anxiety and nervous-system calm, studied as an anxiolytic without the sedation or dependence profile of benzodiazepines. The honest position on both: the mechanisms are interesting, the Russian clinical use is real, the Western trial base is thin, and neither is an approved treatment for PTSD or TBI. They are researched for symptoms that overlap, which is a meaningful but limited thing to be able to say.

BPC-157 and NAD+: The Recovery Side

BPC-157 is best known for tissue repair, and most of its evidence is from animal models. Relevant to this audience, that animal research includes a traumatic brain injury model, where the peptide showed effects worth noting in mice. That is a real and interesting finding, and it is also exactly the kind of finding that gets overstated online, so the caveat has to be loud: an effect in a mouse TBI model is not evidence that it treats human brain injury, and the human trials simply do not exist. For the orthopedic and soft-tissue recovery that many veterans also carry, from injuries sustained in service, the broader tissue-healing research is the more grounded reason it comes up.

NAD+ addresses the energy side. It is a coenzyme present in every cell, central to converting fuel into usable energy, and its levels decline with age and under chronic stress. The rationale for NAD+ therapy is restoring that substrate to support energy and reduce the brain fog that tracks with fatigue. For a veteran whose recovery is dragged down by persistent low energy, that is the lever it speaks to. The same honest caveat applies: the human evidence is mechanistic and emerging, and NAD+ supports recovery rather than treating any underlying condition. None of this replaces sleep, rehabilitation, or the care plan your team has built.

The Research, Honestly

It helps to see the research as an arc rather than a verdict. These compounds have a real scientific history, and they also have real gaps, especially the absence of large human trials in the specific conditions veterans care about. Here is the shape of it.

1980s to 1990s

Semax and Selank developed

Both peptides are developed in Russia, derived from fragments of naturally occurring molecules, and enter clinical use there for cognitive and anxiety indications under the Russian regulatory system.

2010

BPC-157 in a TBI animal model

Preclinical work reports effects of BPC-157 in a traumatic brain injury mouse model. A mechanistically interesting finding, and strictly an animal-model one, not human evidence.

2008

Selank anxiety research

Clinical research examines Selank in generalized anxiety, reporting an anxiolytic effect and a tolerability profile of interest. The work is real but small by the standards of large Western trials.

Today

The honest state of evidence

Mechanisms are plausible and some human data exists for anxiety and cognition, mostly outside the US. Large human trials in veteran TBI and PTSD specifically do not exist. The compounds remain FDA-unapproved and investigational.

Zozulya AA et al. "Efficacy and safety of the novel selank peptide in the treatment of generalized anxiety disorder and comorbid neurasthenia." Bulletin of Experimental Biology and Medicine, 2008. Clinical research on Selank as an anxiolytic. View study

Tudor M et al. "Traumatic brain injury in mice and pentadecapeptide BPC 157 effect." Regulatory Peptides, 2010. Preclinical animal-model research; not human evidence of treatment. View study

U.S. Department of Veterans Affairs, National Center for PTSD. "Traumatic Brain Injury and PTSD." Background on the frequent co-occurrence of TBI and PTSD in veterans and the evidence-based treatments available. View study

Can I Take These With My Meds?

This is the question the sellers skip and the one that matters most, because many veterans are already on medications through the VA, often including SSRIs or other antidepressants for PTSD, anxiety, or depression. Adding a compound on top of an existing medication regimen is not a do-it-yourself decision. It is precisely the kind of thing the provider who manages your medications needs to evaluate.

The serotonin caution, and the rule

Selank influences pathways that interact with the serotonin and GABA systems, so combining it with an SSRI or another serotonergic medication is something a prescriber must evaluate, not something to try on your own. The broader rule applies to all of these: any peptide you are considering should be known to the provider who manages your VA medications, so they can assess interactions and monitor effects. And never stop, lower, or change a prescribed medication on your own to make room for a peptide. That is how people get hurt.

The constructive version of this is coordination, not avoidance. A provider who knows your full medication list and your history can tell you whether a given peptide is a reasonable thing to explore, what to watch for, and how it fits with what you are already taking. That is a service a checkout page cannot provide, and it is the single biggest reason the route into any of this should run through a licensed provider rather than a reseller.

Who This Is For, and Who Should Wait

Ideal for

Veterans already engaged in VA or civilian care who want to ask their provider about adjunct options for specific symptoms like fog, anxiety, low energy, or slow recovery. People who can hold the honest frame that these are investigational, not cures, and not a replacement for established treatment. Those willing to coordinate with the provider who manages their medications before starting anything. Adults seeking support around the edges of a care plan that is already in place.

Consider alternatives if

Anyone in crisis → reach the Veterans Crisis Line at 988, press 1. Peptides are not a crisis tool. Anyone hoping to replace PTSD or TBI treatment → the evidence-based therapies and medications are the care; do not trade them for a peptide. Anyone not ready to involve their prescriber → the medication-interaction risk makes provider coordination non-negotiable. Anyone being sold a "cure" → that claim is a red flag, not a feature.

Sourcing and Logistics

The sourcing risk in this space is real and worth naming directly. A large share of "peptides for veterans" search results are gray-market resellers, some wrapped in veteran-branded marketing, selling "research only" vials with no testing, no provider, and no accountability for what is actually in them. A patriotic label does not make an unregulated product safe. The thing that protects you is the opposite of the gray market: a licensed provider who evaluates your history, a prescription rather than a research-chemical loophole, and a legitimate pharmacy with quality controls.

On the practical side, these peptides are given as subcutaneous injections using a short insulin needle, the standard technique across peptide therapy. PeRx ships them fully reconstituted and ready to use, stored refrigerated at 36 to 46 degrees Fahrenheit. They are dosed on a daily, consistent schedule rather than timed to any particular moment, because the mechanisms work over days and weeks. As with everything in this guide, the logistics are the easy part; the coordination with your care team is the part that actually matters.

Questions Veterans Ask

No, and it is important to be clear about that. Nothing in this guide replaces VA care, trauma-focused therapy, or any medication your provider has prescribed. The evidence-based treatments for TBI and PTSD are the care. Peptides, at most, may play a supportive role around the edges for some people, and only as something coordinated with your care team. Any claim that a peptide can replace that treatment goes well beyond what the evidence supports.
No. Neither is a cure or an approved treatment for PTSD. Selank has been studied for anxiety and Semax for cognition and mood, which are symptom areas that can overlap with PTSD, but research interest in a symptom is not the same as treating the condition. The honest statement is that these may have a supportive role for some people, discussed with a provider, alongside the established treatments that have real evidence. A claim of a cure goes beyond what the research supports.
Bring that question to the provider who prescribes your SSRI before you start anything. The specific concern is that Selank interacts with the serotonin system, so combining it with an SSRI needs a prescriber's evaluation rather than a do-it-yourself trial. More generally, any peptide should be known to the provider managing your medications so they can check for interactions. And never adjust a prescribed medication on your own to accommodate a peptide. Coordination first, always.
None of these peptides is FDA-approved. Semax and Selank are approved and used in Russia, but that is a separate regulatory system and should not be read as US approval or as equivalent evidence. In the US they are investigational, prescription-only compounds available through compounding pharmacies under a provider. That status is exactly why provider oversight and a legitimate pharmacy matter, and why the evidence should be described plainly rather than oversold.
There is no reliable fixed timeline, and expectations should be modest given the limited human evidence. These are not acute, take-one-and-feel-it compounds in the way a stimulant is; the research framing involves use over a period of time. Rather than chasing a specific number, the better approach is to set clear goals with a provider, track how you actually respond, and treat the lack of a guaranteed timeline as part of the honest picture. If something is not helping, that is useful information to bring back to your care team.

Related Guides

Continue reading about peptides and protocols that pair well with this guide.

Talk to a licensed provider

If you want to explore whether any of this fits alongside your care, the right first step is a conversation with a licensed provider who can review your history and your medications. Peptide therapy in the US is prescription-only. Start with the assessment, or read the Selank guide for more detail on the anxiety-focused peptide.

Medical Disclaimer

The information provided on this website, including all articles, guides, and educational content, is for informational and educational purposes only and is not intended as medical advice, diagnosis, or treatment. Nothing on this site should be construed as a substitute for professional medical advice from a qualified healthcare provider.

The majority of peptides discussed on this site are not approved by the U.S. Food and Drug Administration (FDA) for the indications described. They are classified as bulk drug substances and are available only through a licensed prescribing provider and compounding pharmacy. All treatments require a valid prescription and provider oversight.

The majority of published research on peptide therapies has been conducted in preclinical (animal) models. While early human data is encouraging, comprehensive clinical trial data remains limited for most peptide compounds. Individual results may vary significantly based on health status, injury type, and other factors. No specific outcomes are guaranteed.

Certain peptides discussed on this site are classified as prohibited substances by the World Anti-Doping Agency (WADA) and are banned by major sports organizations including the NFL, NCAA, UFC, NBA, MLB, NHL, and PGA. If you are subject to anti-doping testing, consult your governing body before considering any peptide therapy.

Statements on this website have not been evaluated by the Food and Drug Administration. Products and therapies discussed are not intended to diagnose, treat, cure, or prevent any disease.

© 2026 Wellness MD Group PC DBA PeRx. All rights reserved.